Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome

Creative Commons License

Akboga M. K., Yalcin R., Şahinarslan A., Demirtas C., Paşaoğlu H., Abacı A.

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.16, sa.12, ss.953-958, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 12
  • Basım Tarihi: 2016
  • Doi Numarası: 10.14744/anatoljcardiol.2016.6933
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.953-958
  • Anahtar Kelimeler: metabolic syndrome, cardiovascular risk factors, hs-CRP, YKL-40, inflammation, PERIPHERAL ARTERIAL-DISEASE, ALL-CAUSE MORTALITY, C-REACTIVE PROTEIN, INSULIN-RESISTANCE, INFLAMMATORY BIOMARKERS, LYMPHOCYTE RATIO, PLASMA YKL-40, MARKER, RISK, ATHEROSCLEROSIS
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: Metabolic syndrome (MS) is defined by a cluster of interdependent physiological, biochemical, and clinical risk factors and linked to a state of chronic inflammation. YKL-40 is known as an inflammatory glycoprotein, which is secreted by various cell lines during inflammation. Thus, we aimed to assess the association of serum YKL-40 levels with the presence and severity of MS.